<PAGE> 1
2983
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12b-25
Commission File Number 0-11371
CUSIP Number 090908
NOTIFICATION OF LATE FILING
(Check One): / / Form 10-K and Form 10-KSB / / Form 20-F
/ / Form 11-K /X/ Form 10-Q and Form 10-QSB / / Form N-SAR
For Period Ended MARCH 31, 1999
/ / Transition Report on Form 10-K / / Transition Report on Form
10-Q
/ / Transition Report on Form 20-F / / Transition Report on Form
N-SAR
/ / Transition Report on Form 11-K
For the Transition Period
Ended:______________________________________________
Read the attached instruction sheet before preparing form.
Please print or type.
Nothing in this form shall be construed to imply that the
Commission has verified any information contained herein.
If the notification relates to a portion of the filing
checked above identify the Item(s) to which the notification
relates:
_________________________________________________________________
_________________________________________________________________
PART I. REGISTRANT INFORMATION
Full name of registrant BIOSONICS, INC.
Former name if applicable
____________________________________________________
Address of principal executive office (Street and number):
185 COMMERCE DRIVE, SUITE 103
City, State and Zip Code: FT. WASHINGTON, PA 19034
PART II. RULE 12b-25 (b) and (c)
If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks relief
pursuant to Rule 12b-25(b), the following should be completed.
(Check appropriate box.)
/X/ (a) The reasons described in reasonable detail in Part III
of this form could not be eliminated without unreasonable effort
or expense;
/X/ (b) The subject annual report, semi-annual report,
transition report on Form 10-K, 20-F, 11-K or Form N-SAR, or
portion thereof will be filed on or before the 15th calendar day
following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or portion thereof will
be filed on or before the fifth calendar day following the
prescribed due date; and
/ / (c) The accountant's statement or other exhibit required by
Rule 12b-25(c)has been attached if applicable.
PART III. NARRATIVE
State below in reasonable detail the reasons why From 10-K,
11-K, 20-F, 10-Q, N-SAR or the transition report portion thereof
could not be filed within the predescribed time period. (Attach
extra sheets if needed.)
THE COMPANY WAS UNABLE TO OBTAIN THIRD PARTY
INFORMATION RELATING TO THE CONSOLIDATION OF THE SUBSIDIARY
JUST RECENTLY FORMED THEREFORE DELAYING THE ACCOUNTING REVIEW AND
FINALIZATION OF THE REPORTS.
<PAGE> 2
PART IV. OTHER INFORMATION
(1) Name and telephone number of person to contact in regard
to this notification
SANDRA PILEGGI 215 646-7100
(Name) (Area code) (Telephone Number)
(2) Have all other periodic reports required under Section
13 or 15(d) of the Securities Exchange Act of 1934 or Section 30
of the Investment Company Act of 1940 during preceding 12 months
or for such shorter period that the registrant was required to
file such report been filed? If the answer is no, identify
report(s). /X/ Yes / / No
(3) Is it anticipated that any significant change in results
of operations from the corresponding period for the last fiscal
year will be reflected by the earnings statements to be included
in the subject report or portion thereof? / / Yes /X/ No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.
BIOSONICS, INC.
(Name of registrant as specified in charter)
Has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: 5/14/99 By: /S/JACK PALLER
CHIEF EXECUTIVE OFFICER
Instruction. The form may be signed by an executive officer
of the registrant or by any other duly authorized representative.
The name and title of the person signing the form shall be typed
or printed beneath the signature. If the statement is signed on
behalf of the registrant by an authorized representative (other
than an executive officer), evidence of the representative's
authority to sign on behalf of the registrant shall be filed
with the form.
